chrisvoncsefalvay/vaers-outcomes huggingface dataset:
taking new meds for allergic; red spots on roof of mouth; bumps on roof of mouth; rash around the corners of my mouth; sore arm; nausea; headache; This is a spontaneous report from a contactable consumer. This consumer reported for that the 60-year-old female patient who received first dose of bnt162b2 (Pfizer Pfizerbiontech covide-19 Vaccine EUA), via an unspecified route of administration on 03Jan2021 10:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included Known allergies: Penicillin sulfa. No other vaccine in four weeks. Concomitant medications included in two weeks: escitalopram oxalate (LEXAPRO), valaciclovir hydrochloride (VALTREX). The patient experienced Day 1 sore arm, nausea, headache from 05Jan2021 12:00AM, Day 2 nausea from 06Jan2021, Day 3 rash around the corners of my mouth from 07Jan2021, Day 4 bumps on roof of mouth from 08Jan2021, Day 5 red spots on roof of mouth from 09Jan2021, Day 6 Continued red spots went to Doctor, Day 7 taking new meds for allergic reaction from 11Jan2021, Day 8 headache mouth improving. AE resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering. Treatment was received included Doxycycline. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Client developed soreness and swelling in his neck (apparently parotitis) 12 days after receiving his 2nd MMR vaccine.
MODERNA use for COVID-19 under Emergency Use Authorization (EUA): Moderna Covid Vaccine, patient received vaccine on 10/30/21. Patient started to develop petechiae and oral petechiae, was sent to the ED for further evaluation. Patient to have ITP based on platelet findings. No history of ITP, but only significant findings were that she received vaccine on 10/30/21. no hx of ITP, HTN and T2DM
24 hours after injection -injection site moderately sore 48 hrs - site sore and itchy 7 days - red, swollen/hard and itchy
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age. On unspecified dates the patients were vaccinated with GARDASIL (lot number not provided) injections. The patient who had reported having completed her GARDASIL series went for a routine PAP smear and the results showed a high-risk positive PAP which was but 'non HPV 16 and 18'. The outcome of adverse event was unknown. The patient spoke with physician's office for seeking medical attention. Additional information has been requested.
fatigue, headache, muscle pain, joint pain, shills, fever, diarrhea,  stomach pain, fast heartbeat
13Jun90 pt vax.  W/in 10 min devel gen urticaria.  Tx w/ Adrenalin, benadryl, & prednisone.  21Jun90 exp gen hives.  Flew overseas & seen by several MD for urticaria & tx w/ Adrenalin.  25Jun90 exp urticaria on hands & knees.
BUMP ON HAND; BURNING IN HAND; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported.  On 13-APR-2021, the subject experienced bump on hand. On 13-APR-2021, the subject experienced burning in hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bump on hand and burning in hand was not reported. This report was non-serious.
Re-emergence of arm pain/Had cortisone shots 7 weeks and 3 weeks prior to vaccine amd was pain-free.  Several hours after the shot the pain returned on the left side far more severe than previously. Pain is still severe 9 days after the shot; Bulging cervical disks; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6198) via an unspecified route of administration in the left arm on 04May2021, at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included arm pain, bulging cervical disks and allergy to nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included colecalciferol (VITAMIN D3), calcium (MANUFACTURER UNKNOWN), acetylsalicylic acid (BABY ASPIRIN) and an additional medication (reported as neuroma in the source document); all from an unknown date for unknown indications and unknown if ongoing. The patient previously received cortisone shots (MANUFACTURER UNKNOWN); seven weeks and three weeks prior to vaccine in 2021 for arm pain due to bulging cervical disks and was pain-free. On 04May2021, the patient experienced re-emergence of arm pain due to bulging cervical disks. It was reported that, after several hours of the shot the pain returned on the left side far more severe than previously and the pain was still severe nine days after the shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events re-emergence of arm pain due to bulging cervical disks, after several hours of the shot the pain returned on the left side far more severe than previously and the pain was still severe nine days after the shot was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
lethargic; extremely sick; Diarrhea; vomiting; fever; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 22Feb2021 at 12:30 (at the age of 68 year old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD), latex allergy since an unknown date. The patient received prescribed medications/supplement within two weeks of vaccination. The patient previously took Hydrocodeine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, the patient underwent blood test and the result was negative. On 22Feb2021, the patient underwent covid-19 test and the result was negative. On 23Feb2021 at 10:30, the patient was extremely sick with diarrhea, vomiting and a fever of 99 degrees and was lethargic for 3 days following. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events as the physician tested the patient for COVID antibodies test and the result was none. The clinical outcome of the events sick, diarrhea, vomiting, fever and lethargic was recovered with sequelae at the time of this report.  No follow-up attempts are possible. No further information is expected.
Redness, swelling, hot to touch, red streaking, hard to make fist, uncomfortable feeling in whole side of left arm.
Fever of 103 for 8 hours. Uncontrollable crying/screaming for over ten minutes. Diarrhea for 2 weeks.
Minor side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Minor side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Minor side effects). At the time of the report, VACCINATION COMPLICATION (Minor side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided  by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up was received on 21 May 2021 included No NewInformation.
This spontaneous report was received from a medical assistant and refers to a 17 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 25-OCT-2015, the patient was vaccinated with one improperly stored dose of RECOMBIVAX HB 2.5/0.5 (units not provided), which had a lot # of L014878, an expiration date of 17-JAN-2018 (route and anatomical place of vaccination were not provided). The storage detail for the RECOMBIVAX HB was a temperature excursion of 20 F for 24 hours, 24 F for 8 hours, and 27 F for 15 hours. No adverse effect reported. Additional information has been requested.
Chronic swelling and pain in proximal and middle phalanges of right index finger beginning approximately 10 days after injection.  Constant feeling of "trigger" finger in both joints.
Onset of fever, watering eyes, facial redness and "he could not walk at all" on 6.26.2015 per mother's report. Fever of 102.7. Mother treated child with over the counter liquid TYLENOL and patients' symptoms ended on 6/28/2015 and he was able to walk again.
c/o h/a during night had some stomach pains as well as vomit; went to MD 4 days later dizziness occured & h/a remained; was hospitalized 17DEC91 by neurologist for further study; MD did inform mom did not think Td was cause of illness;
nurse rpt several pts & employees after recv Td inject developed redness, swelling, pain & lump.
Acute onset of hyperthyroidism despite having a normal TSH at the end of December. WIthin 1 to 2 weeks of vaccination, palpitations, diarrhea, shortness of breath, tachycardia to 120
Client stated that she developed  a rash on her hands that were extremely red, swollen, and itchy that night after receiving the vaccine. Client stated that she had to go to the doctor to get a a steroid cream to help get them to stop itching, swelling and to help the redness. Client stated that it took 10 days for having the steroid to get the symptoms to stop.
tested positive for COVID-19 with rapid antigen test; tested positive for COVID-19 with rapid antigen test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from regulatory authority.  A 16 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 12Apr2021 (Lot number: EP6955) at the age of 16 years as dose 2, single and intramuscular, administered in arm left, administration date 22Mar2021 (Lot number: EP6955) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). No known allergies. Prior to vaccination, patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No  other medications was received within 2 weeks of vaccination. The following information was reported: On 05Jan2022 11:30, patient tested positive for COVID-19 with rapid antigen test (On/Go/Rapid antigen test, nasal swab) and also experienced fever, headache, sore throat, chills. Therapeutic measures were not taken as a result of the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Error: Wrong route (SC, IM, etc.).
Slight pain and red rash around injection site-2 days ongoing Chills-12 hours after injection, lasting 1 hour Slight fever (1 degree F)-1 day after injection, lasting 12 hours Slight headache (2/10 pain scale)-1 day after injection lasting 3 hours
mom here with child who states symptoms started 02/18/04, 1 day after immunizations were given. Left lat thigh very hot and swollen. Very fussy and was examined earlier by the pulmonologist who referred mom to bring patient here. Examined futher by an ARNP, who instructed mom to give Tylenol gtts prn and apply cool compresses. If symptoms worsen return to clinic or go to emergency dep't.
rash at the injection site that spreads down to the elbow; abnormal pain; hotness to touch; Initial information received on 05-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves an unknown age female patient who experienced rash at the injection site that spreads down to the elbow (rash), abnormal pain (pain) and hotness to touch (skin warm), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 05-Sep-2019, 28-Aug-2019, the patient received a first and second dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and Expiry date unknown) via intramuscular route in unknown administration site.  On an unknown date, the patient developed a non-serious rash at the injection site that spreads down to the elbow (rash), abnormal pain (pain) and hotness to touch (skin warm) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was Localized rash, pain and Skin warm.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Recovering for Localized rash, pain and Skin warm.  Information on the batch number was requested.  List of documents held by sender- none.
Headache, fever, sore throat, tightness of chest, dizziness, rash, blisters,
On 11/8/17 pt complained on 11/7/17 he suffered from redness, itching, tenderness/pain, nausea, and swelling around the injection sites extending to the elbow and shoulder/back. Pt stated he was still suffering tenderness and redness in those areas as of early afternoon 11/8/17. Pt was advised to take BENADRYL and report further symptoms. Pharmacist suggested patient could seek treatment at local urgent care, however, patient declined and decided treat self. Right after being informed the pharmacy contacted the patient's physician about symptoms. On 11/8/17 at 6:10 pm, contact was made with patient at which point patient stated redness and swelling was much better. On 11/11/17 at 9:15 am, contact was made with patient to determine patient's well-being. Patient stated he felt much better and was nearly symptom free.
Patient received booster 12 days before due date and was informed. Patient waited 15 minutes for observation and stated she felt fine no adverse reactions noted or stated by patient.
Information has been received from a physician concerning a 12 month old female with a history of bronchiolitis at 3 month of age, reactive airway issues when sick and was exposure to the stomach virus on 29-DEC-2008 who on 30-DEC-2008 was vaccinated with PNEUMOVAX (lot # 660718/0551X) by accident, IM, 0.5ml. The office was out of PREVENAR and the nurse who administered the PNEUMOVAX vaccine thought it was the same as PREVENAR because she saw the word pneumococcal. On 31-DEC-2008 the patient vomited once and had watery stools that day. The patient went to the emergency room on 31-DEC-2008 and was treated with PHENEGRAN. On 01-JAN-2009 the patient vomited and had 3 or 4 watery stools. At 3:00 am on 02-JAN-2009 the patient threw up once. The patient also had 2 watery stools on 02-JAN-2009. The patient did not perform any lab diagnostics studies. At time of the report, the patient was recovering. Follow-up information has been received from a physician concerning a 12 month old female who on 30-DEC-2008 at 1:26PM was vaccinated with the first dose of PNEUMOVAX vaccine (lot # 660718/0551X) by accident, IM in left leg, 0.5ml. On 31-DEC-2008 the patient developed vomiting and diarrhea that was more likely related to exposure to another child at daycare. Child did go to ER and received antiemetic and did well subsequently. No further information is available.
The morning after receiving the J&J vaccine I had some typical side effects including fever, flu-like and some dizziness/vertigo. The flu-like symptoms only lasted 2 days but the dizziness and vertigo remained. I experience brain fog, dizziness, vertigo, and problems with memory on a daily basis since then, which has been over 5 months. As of about 3 weeks ago I am now experiencing tingling in my hands and feet, burning pins and needles feeling in my back and difficulty with emptying my bladder completely. My symptoms seem to be getting worse
Developed flu-like symptoms with swollen joints, myalgias, arthralgias, and low grade temperature within 12 hours of administration.
Experienced stomach upset, nausea, fever 101.4, body aches, inability to focus
Pt recv vax on 3/8/99; on 3/11/99 pt exp blurred vision; dx=possible optic neuritis
Getting the shot hurts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Getting the shot hurts) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Getting the shot hurts). At the time of the report, VACCINATION SITE PAIN (Getting the shot hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.
This spontaneous report was received from an office manager referring to a female patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 21-SEP-2018, the patient was vaccinated with an expired dose of VAQTA lot number N020503 and expiration date of 04-SEP-2018 intramuscularly for prophylaxis (dose and anatomical location date were not reported). No adverse effects were reported.
Slight fever; redness, swelling and tenderness where shot was given, tiredness and poor appetite.
COULDN'T LIFT/ MOVE HER RIGHT ARM; RASH TO HER CHEST, ARMS, LEGS; PAINFUL AT INJECTION SITE; HAIR STARTED FALLING OUT; SCALP IS SORE/BURNING; This spontaneous report received from a patient concerned a 79 year old female. The patient's weight was 145 pounds, and height was 62 inches. The patient's concurrent conditions included: sleep/anxiety, seasonal allergies, and environmental allergies, and other pre-existing medical conditions included: Patient was not pregnant at the time of report. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, route of admin not reported, batch number: 1802068 expiry: 23-AUG-2021) dose was not reported, 1 total, administered to right arm on 10-MAR-2021 for prophylactic vaccination.  On an unspecified date, the patient was not feeling well following vaccination with covid-19 vaccine ad26.cov2.s and went to the Emergency Department and there had a positive COVID-19 PCR (polymerase chain reaction) test confirmation of COVID -19 infection. The patient was subsequently hospitalized for 3 days. On an unspecified date, the patient experienced confirmed clinical vaccination failure (dose number in series: 1). On 28-SEP-2021, Laboratory data included: COVID-19 PCR (polymerase chain reaction) test (NR: not provided) positive. The patient received covid-19 vaccine ad26.cov2.s (dose number in series: 2) (suspension for injection, route of admin not reported, batch number: 1855194 expiry: 09-APR-2022) dose was not reported, 1 total, administered to right arm on 28-OCT-2021 for prophylactic vaccination. Concomitant medications included alprazolam for sleep/anxiety.  On an unspecified date, the patient experienced couldn't lift/ move her right arm, rash to her chest, arms, legs, and painful at injection site following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series: 2). It was reported that the patient's hair/scalp felt strange ever since positive COVID diagnosis. The patient added that she was told by her HCP that if not for being vaccinated, she may have needed intubation. (dose number in series: 2) On 16-DEC-2021, the patient experienced hair started falling out, and scalp is sore/burning dose number in series: 2).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash to her chest, arms, legs, and painful at injection site, had not recovered from hair started falling out, and the outcome of couldn't lift/ move her right arm and scalp is sore/burning was not reported. This report was non-serious. This case, involving the same patient is linked to 20220104484. (dose number in series: 1)
4mins post vaccination pt reported nausea.  Vitals: 97/60, 80, 118. Pt given apple juice @14:35. Pt stable and released from the vaccination site @14:43.  NAD.  Feeling better and accompanied by mother.
Initial report received on 10 November 206 a health care professional. A 45-year-old female patient had inadvertently received a left deltoid, intramuscular injection of Daptacel, (product not recommended for use in this age group), lot number C2630AA, on 01 September 2006. This product was administered instead of Adacel. The following day, the patient experienced muscle soreness, and she had a local reaction of redness and it was indurated. No testing or examination by a physician was required. The patient took nonsteroidal anti-inflammatory medications as noted. The patient recovered from the injection site redness and induration six to eight hours after onset of the adverse event. The patient recovered from the muscle soreness within 96 hours after onset of the adverse event.
Patient was seen in clinic today for back to school immunizations. She was administered Boostrix and Menactra IM to her Left Deltoid and then Gardasil 9 IM to her Right Deltoid. Patient remained seated in the nurses office for 5-10 minutes afterwards and was given a snack. Patient and parent then stated that they were ready to leave and were asked to wait in the front lobby for patient's printed certificate of immunization.  Per front staff - patient and her mother were standing at the front window waiting on her certificate of immunization when patient told her mother she was feeling dizzy. Patient's mother lowered her to the floor (she did not fall or hit her head). Nursing staff were then called to assess patient she was conscious by the time nursing got to her and mother reported patient only lost consciousness for about 5-10 seconds.  Patient was assisted into chair, cool cloth applied to neck and head, and some soda was given. Patient was monitored by nursing staff for 15-25 minutes. Patient and mother reported that patient was feeling much better and they left (mother was instructed to contact 911 if patient started to display any s/s of distress and she voiced understanding).
Swelling, redness, tenderness at injection site and radiating about 3 inches below site.
Erythema, swelling with warmth at injection site of DTAP and IPV, 3 days after injections.
Uveitis and vasculitis - abdominal cramping, fever, rash, body aches, eye pain and inflammation